Akcea Therapeutics Inc. (AKCA) NASDAQ/NGS (GLOBAL SELECT MARKET)
$18.17 - (-)
Market Cap: -
As of 10/09/20 12:00 AM EDT. Market closed.
Akcea Therapeutics Inc. (AKCA)
NASDAQ/NGS (GLOBAL SELECT MARKET)
$18.17
- (-)
Market Cap: -
As of 10/09/20 12:00 AM EDT. Market closed.
Add to Portfolio
... read more
COMPANY PROFILE
Sector
Manufacturing
Industry
Medicinal and Botanical Manufacturing
CEO Compensation (Base)
$500,597
CEO Compensation (Total)
$5.21M
Sector
Manufacturing
Industry
Medicinal and Botanical Manufacturing
CEO
Damien McDevitt
CEO Compensation (Base)
$500,597
CEO Compensation (Total)
$5.21M
URL
Address
22 Boston Wharf Rd Fl 9, Massachusetts, Boston, 02210-1838.
PRICE CHART FOR AKCEA THERAPEUTICS INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
$18.17
Days Range
- - -
52 week range
- - -
Volume
0
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
101,598,619
Open
-
Previous Close
$18.17
Days Range
- - -
52 week range
- - -
Volume
0
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
101,598,619
FINANCIAL STATEMENTS FOR AKCEA THERAPEUTICS INC
LOADING...
INSIDER TRANSACTIONS FOR AKCEA THERAPEUTICS INC
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
IONIS PHARMACEUTICALS INC | 10% Owner | Oct 10, 2020 | Buy | $18.15 | 21,237,715 | 385,464,519 | 98,322,397 | Oct 14, 2020, 04:05 PM |
PRICE MICHAEL DENNIS | Chief Financial Officer | Oct 12, 2020 | Option Exercise | $18.15 | 50,000 | 907,500 | 0 | Oct 13, 2020, 04:04 PM |
Patterson Joshua F. | General Counsel | Oct 12, 2020 | Option Exercise | $18.15 | 26,532 | 481,556 | 0 | Oct 13, 2020, 04:02 PM |
Jenne Kyle | Chief Commercial Officer | Oct 12, 2020 | Option Exercise | $18.15 | 52,012 | 944,018 | 0 | Oct 13, 2020, 03:59 PM |
Howarth Alex G. | Chief Operating Officer | Oct 12, 2020 | Option Exercise | $18.15 | 66,800 | 1,212,420 | 0 | Oct 13, 2020, 03:58 PM |
Andrews William T. | Chief Medical Officer | Oct 12, 2020 | Option Exercise | $18.15 | 37,500 | 680,625 | 0 | Oct 13, 2020, 03:56 PM |
McDevitt Damien | Chief Executive Officer | Oct 12, 2020 | Option Exercise | $18.15 | 242,978 | 4,410,051 | 0 | Oct 13, 2020, 03:54 PM |
Patterson Joshua F. | General Counsel | Sep 22, 2020 | Sale | $18.12 | 319 | 5,780 | 26,532 | Sep 24, 2020, 04:25 PM |
Jenne Kyle | Chief Commercial Officer | Sep 22, 2020 | Sale | $18.12 | 720 | 13,046 | 52,012 | Sep 24, 2020, 04:21 PM |
McDevitt Damien | Chief Executive Officer | Sep 22, 2020 | Sale | $18.12 | 8,709 | 157,807 | 242,978 | Sep 24, 2020, 04:19 PM |
McDevitt Damien | Chief Executive Officer | Aug 31, 2020 | Option Exercise | $14.40 | 1,104 | 15,896 | 251,687 | Sep 02, 2020, 04:20 PM |
Patterson Joshua F. | General Counsel | Jul 17, 2020 | Sale | $12.50 | 263 | 3,288 | 26,851 | Jul 20, 2020, 05:18 PM |
Patterson Joshua F. | General Counsel | Mar 23, 2020 | Sale | $11.76 | 335 | 3,938 | 14,614 | Mar 25, 2020, 04:44 PM |
Jenne Kyle | Chief Commercial Officer | Mar 23, 2020 | Sale | $11.75 | 779 | 9,153 | 52,732 | Mar 25, 2020, 04:43 PM |
O'Dea Louis | Chief Medical Officer | Mar 23, 2020 | Sale | $11.75 | 3,198 | 37,579 | 61,602 | Mar 25, 2020, 04:42 PM |
McDevitt Damien | Chief Executive Officer | Mar 23, 2020 | Sale | $11.75 | 9,417 | 110,649 | 245,783 | Mar 25, 2020, 04:41 PM |
Goldberg Jeff Marc | Chief Operating Officer | Sep 26, 2019 | Option Exercise | $16.64 | 268,111 | 4,461,367 | 156,631 | Sep 30, 2019, 09:26 PM |
Goldberg Jeff Marc | Chief Operating Officer | Sep 26, 2019 | Option Exercise | $6.96 | 421,432 | 2,932,747 | 305,560 | Sep 30, 2019, 09:26 PM |
Soteropoulos Paula | Chief Executive Officer | Sep 26, 2019 | Option Exercise | $16.64 | 1,383,712 | 23,024,967 | 678,149 | Sep 30, 2019, 05:52 PM |
Soteropoulos Paula | Chief Executive Officer | Sep 26, 2019 | Option Exercise | $7.05 | 2,061,861 | 14,538,254 | 1,711,079 | Sep 30, 2019, 05:52 PM |
Boyce Sarah | President | Jul 15, 2019 | Sale | $23.52 | 1,819 | 42,783 | 19,888 | Jul 17, 2019, 04:52 PM |
Boyce Sarah | President | Jul 01, 2019 | Option Exercise | $20.04 | 813 | 16,295 | 21,707 | Jul 03, 2019, 04:31 PM |
Goldberg Jeff Marc | Chief Operating Officer | Jul 01, 2019 | Option Exercise | $20.04 | 430 | 8,618 | 3,310 | Jul 03, 2019, 04:28 PM |
Goldberg Jeff Marc | Chief Operating Officer | Apr 08, 2019 | Option Exercise | $6.48 | 20,000 | 129,600 | 22,880 | Apr 09, 2019, 07:00 PM |
Goldberg Jeff Marc | Chief Operating Officer | Apr 05, 2019 | Option Exercise | $6.48 | 30,000 | 194,400 | 32,880 | Apr 09, 2019, 07:00 PM |
Goldberg Jeff Marc | Chief Operating Officer | Apr 05, 2019 | Sale | $31.71 | 30,000 | 951,300 | 2,880 | Apr 09, 2019, 07:00 PM |
Goldberg Jeff Marc | Chief Operating Officer | Apr 08, 2019 | Sale | $31.72 | 20,000 | 634,418 | 2,880 | Apr 09, 2019, 07:00 PM |
Soteropoulos Paula | Chief Executive Officer | Apr 08, 2019 | Option Exercise | $6.48 | 1,787 | 11,580 | 1,787 | Apr 09, 2019, 06:59 PM |
Soteropoulos Paula | Chief Executive Officer | Apr 05, 2019 | Option Exercise | $6.48 | 30,000 | 194,400 | 30,000 | Apr 09, 2019, 06:59 PM |
Soteropoulos Paula | Chief Executive Officer | Apr 08, 2019 | Sale | $32.17 | 1,787 | 57,480 | 0 | Apr 09, 2019, 06:59 PM |
Soteropoulos Paula | Chief Executive Officer | Apr 05, 2019 | Sale | $32.11 | 30,000 | 963,300 | 0 | Apr 09, 2019, 06:59 PM |
Soteropoulos Paula | Chief Executive Officer | Mar 06, 2019 | Option Exercise | $6.48 | 18,386 | 119,141 | 18,386 | Mar 07, 2019, 05:20 PM |
Soteropoulos Paula | Chief Executive Officer | Mar 06, 2019 | Sale | $32.14 | 18,386 | 590,856 | 0 | Mar 07, 2019, 05:20 PM |
Goldberg Jeff Marc | Chief Operating Officer | Jan 01, 2019 | Option Exercise | $21.51 | 493 | 10,606 | 2,880 | Jan 04, 2019, 05:33 PM |
Goldberg Jeff Marc | Chief Operating Officer | Jul 01, 2018 | Option Exercise | $14.77 | 1,398 | 20,653 | 2,387 | Jul 02, 2018, 07:10 PM |
IONIS PHARMACEUTICALS INC | 10% Owner | Apr 17, 2018 | Buy | $18.75 | 10,666,666 | 199,999,988 | 64,114,545 | Apr 19, 2018, 06:48 PM |
Goldberg Jeff Marc | Chief Operating Officer | Jan 01, 2018 | Option Exercise | $6.80 | 989 | 6,725 | 989 | Jan 04, 2018, 07:00 PM |
IONIS PHARMACEUTICALS INC | 10% Owner | Jul 19, 2017 | Buy | $8.00 | 3,125,000 | 25,000,000 | 45,447,879 | Jul 21, 2017, 04:04 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
Owner | Relationship | Date | Value($) |
IONIS PHARMACEUTICALS INC | 10% Owner | 10/10/2020 | 385,464,519 |
PRICE MICHAEL DENNIS | Chief Financial Officer | 10/12/2020 | 907,500 |
Patterson Joshua F. | General Counsel | 10/12/2020 | 481,556 |
Jenne Kyle | Chief Commercial Officer | 10/12/2020 | 944,018 |
Howarth Alex G. | Chief Operating Officer | 10/12/2020 | 1,212,420 |
Andrews William T. | Chief Medical Officer | 10/12/2020 | 680,625 |
McDevitt Damien | Chief Executive Officer | 10/12/2020 | 4,410,051 |
Patterson Joshua F. | General Counsel | 09/22/2020 | 5,780 |
Jenne Kyle | Chief Commercial Officer | 09/22/2020 | 13,046 |
McDevitt Damien | Chief Executive Officer | 09/22/2020 | 157,807 |
McDevitt Damien | Chief Executive Officer | 08/31/2020 | 15,896 |
Patterson Joshua F. | General Counsel | 07/17/2020 | 3,288 |
Patterson Joshua F. | General Counsel | 03/23/2020 | 3,938 |
Jenne Kyle | Chief Commercial Officer | 03/23/2020 | 9,153 |
O'Dea Louis | Chief Medical Officer | 03/23/2020 | 37,579 |
McDevitt Damien | Chief Executive Officer | 03/23/2020 | 110,649 |
Goldberg Jeff Marc | Chief Operating Officer | 09/26/2019 | 4,461,367 |
Goldberg Jeff Marc | Chief Operating Officer | 09/26/2019 | 2,932,747 |
Soteropoulos Paula | Chief Executive Officer | 09/26/2019 | 23,024,967 |
Soteropoulos Paula | Chief Executive Officer | 09/26/2019 | 14,538,254 |
Boyce Sarah | President | 07/15/2019 | 42,783 |
Boyce Sarah | President | 07/01/2019 | 16,295 |
Goldberg Jeff Marc | Chief Operating Officer | 07/01/2019 | 8,618 |
Goldberg Jeff Marc | Chief Operating Officer | 04/08/2019 | 129,600 |
Goldberg Jeff Marc | Chief Operating Officer | 04/05/2019 | 194,400 |
Goldberg Jeff Marc | Chief Operating Officer | 04/05/2019 | 951,300 |
Goldberg Jeff Marc | Chief Operating Officer | 04/08/2019 | 634,418 |
Soteropoulos Paula | Chief Executive Officer | 04/08/2019 | 11,580 |
Soteropoulos Paula | Chief Executive Officer | 04/05/2019 | 194,400 |
Soteropoulos Paula | Chief Executive Officer | 04/08/2019 | 57,480 |
Soteropoulos Paula | Chief Executive Officer | 04/05/2019 | 963,300 |
Soteropoulos Paula | Chief Executive Officer | 03/06/2019 | 119,141 |
Soteropoulos Paula | Chief Executive Officer | 03/06/2019 | 590,856 |
Goldberg Jeff Marc | Chief Operating Officer | 01/01/2019 | 10,606 |
Goldberg Jeff Marc | Chief Operating Officer | 07/01/2018 | 20,653 |
IONIS PHARMACEUTICALS INC | 10% Owner | 04/17/2018 | 199,999,988 |
Goldberg Jeff Marc | Chief Operating Officer | 01/01/2018 | 6,725 |
IONIS PHARMACEUTICALS INC | 10% Owner | 07/19/2017 | 25,000,000 |
Load More Insider Transactions
BUYBACK ANNOUNCEMENT(S) FOR AKCEA THERAPEUTICS INC
LOADING...